Molecular Partners(DE:6ML0)
€2.64-0.02 (-2.94%)
DE:6ML0
Molecular Partners financials statements
€2.64
At close:-0.02 (-2.94%)
Molecular Partners (6ML0) Ratios
0 Followers
Molecular Partners Ratios
DE:6ML0's free cash flow for Q3 2026 was CHF-10.51M. For the 2026 fiscal year, DE:6ML0's free cash flow was increased by CHF134.00 and operating cash flow was CHF-10.51M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.79 | 14.31 | 13.35 | 14.77 | 3.50 |
| Quick Ratio | 8.79 | 14.31 | 13.35 | 14.77 | 3.50 |
| Cash Ratio | 7.50 | 5.92 | 4.67 | 5.10 | 1.53 |
| Solvency Ratio | -2.73 | -3.06 | -2.72 | 4.44 | -0.94 |
| Operating Cash Flow Ratio | -4.65 | -5.49 | -4.09 | 6.87 | -1.94 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | CHF 75.10M | CHF 137.39M | CHF 170.54M | CHF 227.66M | CHF 98.81M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.02 | 0.02 | 0.02 | 0.03 |
| Debt-to-Equity Ratio | 0.05 | 0.02 | 0.02 | 0.02 | 0.06 |
| Debt-to-Capital Ratio | 0.04 | 0.02 | 0.02 | 0.02 | 0.05 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.27 | 1.12 | 1.12 | 1.12 | 1.61 |
| Debt Service Coverage Ratio | -3304.94 | -2065.96 | -1214.59 | 183.61 | -99.75 |
| Interest Coverage Ratio | -3229.11 | -2448.68 | -1247.10 | 179.92 | -104.28 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.10 | 0.07 | 0.11 | 0.17 | 0.21 |
| Net Debt to EBITDA | 1.33 | 1.19 | 1.07 | -0.70 | 1.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | -855.81% | -579.80% | 73.23% | -497.19% |
| EBIT Margin | 0.00% | -1086.84% | -880.22% | 61.52% | -677.67% |
| EBITDA Margin | 0.00% | -1039.18% | -845.62% | 62.78% | -650.18% |
| Operating Profit Margin | 0.00% | -1231.73% | -868.26% | 61.52% | -679.72% |
| Pretax Profit Margin | 0.00% | -1087.34% | -880.70% | 62.17% | -683.63% |
| Net Profit Margin | 0.00% | -1087.38% | -880.70% | 62.17% | -683.65% |
| Continuous Operations Profit Margin | 0.00% | -1087.38% | -880.70% | 62.17% | -683.65% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 106.06% | 88.28% | 101.43% | 101.06% | 100.58% |
| Return on Assets (ROA) | -60.38% | -34.09% | -31.25% | 44.94% | -36.94% |
| Return on Equity (ROE) | -76.74% | -38.16% | -35.13% | 50.11% | -59.45% |
| Return on Capital Employed (ROCE) | -63.82% | -41.43% | -33.22% | 47.60% | -50.41% |
| Return on Invested Capital (ROIC) | -62.98% | -41.10% | -33.01% | 47.36% | -49.94% |
| Return on Tangible Assets | -60.38% | -34.10% | -31.28% | 44.98% | -37.01% |
| Earnings Yield | -47.83% | -36.83% | -53.82% | 59.96% | -11.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 17.38 | 4.03 | 111.63 | 0.36 |
| Payables Turnover | 2.19 | 69.96 | 116.69 | 50.90 | 11.46 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 27859000.00 |
| Fixed Asset Turnover | 0.00 | 1.18 | 1.24 | 26.20 | 1.15 |
| Asset Turnover | 0.00 | 0.03 | 0.04 | 0.72 | 0.05 |
| Working Capital Turnover Ratio | 0.00 | 0.03 | 0.03 | 1.07 | 0.08 |
| Cash Conversion Cycle | -166.95 | 15.79 | 87.37 | -3.90 | 974.58 |
| Days of Sales Outstanding | 0.00 | 21.00 | 90.50 | 3.27 | 1006.43 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 166.95 | 5.22 | 3.13 | 7.17 | 31.85 |
| Operating Cycle | 0.00 | 21.00 | 90.50 | 3.27 | 1006.43 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.38 | -1.74 | -1.80 | 3.65 | -2.93 |
| Free Cash Flow Per Share | -1.39 | -1.76 | -1.83 | 3.61 | -2.98 |
| Dividend Paid and CapEx Coverage Ratio | -71.79 | -81.95 | -102.62 | 83.67 | -69.59 |
| Capital Expenditure Coverage Ratio | -71.79 | -81.95 | -102.62 | 83.67 | -69.59 |
| Operating Cash Flow Coverage Ratio | -14.07 | -24.24 | -16.16 | 24.45 | -15.06 |
| Operating Cash Flow to Sales Ratio | 0.00 | -11.92 | -8.38 | 0.63 | -9.75 |
| Free Cash Flow Yield | -40.32% | -40.87% | -51.94% | 59.60% | -17.02% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.10 | -2.71 | -1.86 | 1.67 | -8.50 |
| Price-to-Sales (P/S) Ratio | 0.00 | 29.53 | 16.36 | 1.04 | 58.11 |
| Price-to-Book (P/B) Ratio | 1.60 | 1.04 | 0.65 | 0.84 | 5.05 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.48 | -2.45 | -1.93 | 1.68 | -5.88 |
| Price-to-Operating Cash Flow Ratio | -2.51 | -2.48 | -1.95 | 1.66 | -5.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.56 | 0.17 | 0.01 | -0.01 | 0.47 |
| Enterprise Value Multiple | -0.84 | -1.65 | -0.87 | 0.95 | -7.85 |
| Enterprise Value | 49.88M | 85.31M | 51.51M | 113.45M | 476.38M |
| EV to EBITDA | -0.84 | -1.65 | -0.87 | 0.95 | -7.85 |
| EV to Sales | 0.00 | 17.17 | 7.32 | 0.60 | 51.06 |
| EV to Free Cash Flow | -0.96 | -1.42 | -0.86 | 0.97 | -5.16 |
| EV to Operating Cash Flow | -0.97 | -1.44 | -0.87 | 0.96 | -5.24 |
| Tangible Book Value Per Share | 2.16 | 4.16 | 5.38 | 7.23 | 3.45 |
| Shareholders’ Equity Per Share | 2.16 | 4.16 | 5.38 | 7.24 | 3.46 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.15 | 0.21 | 5.84 | 0.30 |
| Net Income Per Share | -1.65 | -1.59 | -1.89 | 3.63 | -2.06 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 9.78 | 6.93 | 0.27 | 5.97 |
| SG&A to Revenue | 0.00 | 3.45 | 2.70 | 0.12 | 1.81 |
| Stock-Based Compensation to Revenue | 0.00 | 0.83 | 0.74 | 0.03 | 0.44 |
| Income Quality | 0.83 | 1.10 | 0.95 | 1.01 | 1.43 |
Currency in CHF
